Market Overview:
The global amoxicillin drug market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of infectious diseases, rising demand for generic drugs, and growing number of mergers and acquisitions among pharmaceutical companies. Based on type, the global amoxicillin drug market can be segmented into capsule, tablet, and other segments. The capsule segment is expected to account for a major share of the global amoxicillin drug market in 2018 owing to its high demand among patients. By application, the hospital pharmacy segment is expected to account for a major share of the global amoxicillin drug market in 2018 owing to its high usage rates in hospitals across the world.
Product Definition:
The drug amoxicillin is a penicillin antibiotic used to treat various infections caused by bacteria, such as pneumonia, bronchitis, and ear infections.
Capsule:
Capsule is a hard gelatin capsule with an internal dose of the drug. It serves as a delivery system for all sizes of molecules, especially small ones like antibiotics which are prone to degradation when administered in liquid form. The size and shape of the capsule allows it to pass through the digestive tract without being destroyed or changed in any way; this property is very important for drugs that must be kept under certain limits (as per FDA) of stability during administration.
Tablet:
Tablet is a form of oral drug delivery which comprises an inert solid dosage excipient, and the active pharmaceutical ingredient. The two most commonly used excipients for manufacturing tablets are starch and lactose. Amoxicillin tablet consists of amoxicillin trihydrate (3H). It is widely prescribed for bacterial infections in children as well as adults.
Application Insights:
Hospital pharmacy held the largest share of over 75.0% in 2017. Amoxicillin is widely used in hospital pharmacies for the treatment of various infections including pneumonia, skin infections, urinary tract infections and respiratory tract infections. The widespread use of amoxicillin in hospital pharmacies is expected to drive growth during the forecast period as it reduces cost and offers better patient compliance as compared to other antibiotic drugs.
Amoxicillin tablets are available with a prescription only from a healthcare professional and are therefore more expensive than other generic antibiotics that can be purchased without a prescription from local supermarkets, retail pharmacies or medicine stores. This factor has restrained market growth over the past few years but will not hinder its growth prospects during the forecast period due to growing demand for amoxicillin capsules at affordable prices among general consumers especially in developing countries such as India, China etc.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of infectious diseases, rising geriatric population, and high adoption of online shopping. Moreover, presence of key players such as Pfizer Inc.; Mylan N.V.; Abbott Laboratories; and Merck & Co., Inc.
Asia Pacific is anticipated to be one of the fastest-growing regions during the same period owing to growing healthcare expenditure in emerging countries such as China.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the global amoxicillin drug market. Amoxicillin is a widely prescribed antibiotic for the treatment of various types of infections, including respiratory tract infections, skin infections, and urinary tract infections.
- Rising demand from emerging markets: The demand for amoxicillin drugs is rising rapidly in emerging markets such as China and India due to the increasing prevalence of infectious diseases and growing awareness about the benefits of antibiotics among patients and healthcare professionals.
- Technological advancements: The development of new formulations and delivery systems for amoxicillin drugs is helping to expand their use in a wider range of indications, thereby driving market growth. For instance, Amoxil (amoxicillin) oral suspension was recently approved by the US FDA for treating pediatric patients with acute otitis media (AOM).
- Growing popularity among pregnant women: There has been a significant increase in the use of amoxicillin by pregnant women over recent years due to its safety profile and efficacy in treating various typesof infection during pregnancy.. This is expected to drive market growth overthe forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Amoxicillin Drug Market Research Report
By Type
Capsule, Tablet, Other
By Application
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
By Companies
GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
132
Number of Tables & Figures
93
Customization Available
Yes, the report can be customized as per your need.
Global Amoxicillin Drug Market Report Segments:
The global Amoxicillin Drug market is segmented on the basis of:
Types
Capsule, Tablet, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Novartis
- Centrient Pharma
- Teva
- Mylan
- Cipla
- NCPC
- United Laboratories
- Sun Pharma
- CSPC
- LKPC
- Hikma
- Dr. Reddy
- HPGC
- Aurubindo
- Meiji Holdings
Highlights of The Amoxicillin Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Capsule
- Tablet
- Other
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Amoxicillin Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Amoxicillin is a type of antibiotic. It is used to treat infections caused by bacteria. Amoxicillin can be taken by mouth or injected into the bloodstream.
Some of the key players operating in the amoxicillin drug market are GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings.
The amoxicillin drug market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Amoxicillin Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Amoxicillin Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Amoxicillin Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Amoxicillin Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Amoxicillin Drug Market Size & Forecast, 2020-2028
4.5.1 Amoxicillin Drug Market Size and Y-o-Y Growth
4.5.2 Amoxicillin Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Capsule
5.2.2 Tablet
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Online Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Amoxicillin Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Amoxicillin Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Capsule
9.6.2 Tablet
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacy
9.10.3 Online Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Capsule
10.6.2 Tablet
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacy
10.10.3 Online Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Capsule
11.6.2 Tablet
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacy
11.10.3 Online Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Capsule
12.6.2 Tablet
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacy
12.10.3 Online Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Capsule
13.6.2 Tablet
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacy
13.10.3 Online Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Amoxicillin Drug Market: Competitive Dashboard
14.2 Global Amoxicillin Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GSK
14.3.2 Novartis
14.3.3 Centrient Pharma
14.3.4 Teva
14.3.5 Mylan
14.3.6 Cipla
14.3.7 NCPC
14.3.8 United Laboratories
14.3.9 Sun Pharma
14.3.10 CSPC
14.3.11 LKPC
14.3.12 Hikma
14.3.13 Dr. Reddy
14.3.14 HPGC
14.3.15 Aurubindo
14.3.16 Meiji Holdings
